JPS5418330B2
(xx)
*
|
1973-03-16 |
1979-07-06 |
|
|
US3966905A
(en)
*
|
1973-05-29 |
1976-06-29 |
Barnes-Hind Pharmaceuticals, Inc. |
Stabilized catechol amine solutions
|
US3929989A
(en)
*
|
1974-06-14 |
1975-12-30 |
Wendt Lab Inc |
Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
|
GB1538903A
(en)
*
|
1975-04-11 |
1979-01-24 |
Nelson Res & Dev |
Carrier for a topically applied physiologically active agent or cosmetic agent
|
US4018889A
(en)
*
|
1976-01-02 |
1977-04-19 |
Pfizer Inc. |
Oxytetracycline compositions
|
DE2602363C2
(de)
*
|
1976-01-22 |
1984-04-12 |
Bayer Ag, 5090 Leverkusen |
Wäßrige, injizierbare Niclofolan- Formulierungen
|
GB1592053A
(en)
*
|
1976-12-16 |
1981-07-01 |
Norbrook Lab Ltd |
Oxytetracycline compositions
|
US4213963A
(en)
*
|
1978-12-14 |
1980-07-22 |
Janssen Pharmaceutica N.V. |
Fluspirilene-containing compositions
|
US4259331A
(en)
*
|
1979-04-16 |
1981-03-31 |
Pfizer Inc. |
Oxytetracycline compositions
|
US4386083A
(en)
*
|
1980-04-10 |
1983-05-31 |
Walter Hacke |
Injectable oxytetracycline compositions
|
US4399127A
(en)
*
|
1980-04-10 |
1983-08-16 |
Diamond Shamrock Corporation |
Injectable oxytetracycline compositions
|
IE74244B1
(en)
*
|
1985-10-01 |
1997-07-16 |
Bimeda Res Dev Ltd |
A process for preparing an antibiotic composition
|
US5071643A
(en)
*
|
1986-10-17 |
1991-12-10 |
R. P. Scherer Corporation |
Solvent system enhancing the solubility of pharmaceuticals for encapsulation
|
US6756365B2
(en)
*
|
1991-11-06 |
2004-06-29 |
Trustees Of Tufts College |
Reducing tetracycline resistance in living cells
|
EP0626171A1
(de)
*
|
1993-05-26 |
1994-11-30 |
Winfried Dörnhöfer |
Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
|
US6383515B2
(en)
|
1999-05-28 |
2002-05-07 |
Sawyer Maryjean |
Solvent system for enhancing solubility
|
US6500812B2
(en)
|
1999-09-14 |
2002-12-31 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
US6849615B2
(en)
|
1999-09-14 |
2005-02-01 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
US8106225B2
(en)
*
|
1999-09-14 |
2012-01-31 |
Trustees Of Tufts College |
Methods of preparing substituted tetracyclines with transition metal-based chemistries
|
EP2327686A3
(en)
|
1999-09-14 |
2012-08-22 |
Trustees Of Tufts College |
Methods of preparing substituted tetracyclines with transition metal-based chemistries
|
AU3105801A
(en)
*
|
2000-01-24 |
2001-07-31 |
Trustees Of Tufts College |
Tetracycline compounds for treatment of cryptosporidium parvum related disorders
|
AR033361A1
(es)
*
|
2000-03-31 |
2003-12-17 |
Tufts College |
Compuestos de tetraciclina 7- y/o 9- sustituidos y las correspondientes composiciones farmaceuticas, metodos para sintesis e intermediarios reactivos y metodos para tratar estados sensibles a la tetraciclina en mamiferos
|
DE60102815D1
(de)
*
|
2000-05-15 |
2004-05-19 |
Paratek Pharm Innc |
7-substituierte kondensierte ring-tetrazyclin- verbindungen
|
US20040224927A1
(en)
*
|
2000-06-16 |
2004-11-11 |
Trustees Of Tufts College |
7-N-substituted phenyl tetracycline compounds
|
US20020132798A1
(en)
*
|
2000-06-16 |
2002-09-19 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
US20020128238A1
(en)
*
|
2000-06-16 |
2002-09-12 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
KR101027625B1
(ko)
*
|
2000-07-07 |
2011-04-06 |
파라테크 파마슈티컬스, 인크. |
7-치환 테트라사이클린 화합물
|
US20050143353A1
(en)
*
|
2000-07-07 |
2005-06-30 |
Paratek Pharmaceuticals, Inc. |
13-Substituted methacycline compounds
|
DE60144375D1
(de)
|
2000-07-07 |
2011-05-19 |
Trustees Of Tufts College Medford |
7-, 8- und 9-substitutierte tetracyclinverbindungen
|
CA2415172A1
(en)
|
2000-07-07 |
2002-01-17 |
Mark L. Nelson |
13-substituted methacycline compounds
|
US7094806B2
(en)
*
|
2000-07-07 |
2006-08-22 |
Trustees Of Tufts College |
7, 8 and 9-substituted tetracycline compounds
|
US6846939B2
(en)
|
2000-07-07 |
2005-01-25 |
Paratek Pharmaceuticals, Inc. |
9-substituted minocycline compounds
|
WO2002072506A2
(en)
*
|
2001-03-13 |
2002-09-19 |
Paratek Pharmaceuticals, Inc. |
7-pyrollyl tetracycline compounds and methods of use thereof
|
MXPA03008165A
(es)
|
2001-03-13 |
2003-12-12 |
Paratek Pharm Innc |
Compuestos tetraciclina sustituidos en la posicion 7,9.
|
JP2005504722A
(ja)
|
2001-03-14 |
2005-02-17 |
パラテック ファーマシューティカルズ インコーポレイテッド |
相乗的抗真菌薬剤としての置換テトラサイクリン化合物
|
CA2457234A1
(en)
*
|
2001-03-14 |
2002-09-19 |
Mark L. Nelson |
Substituted tetracycline compounds as antifungal agents
|
EP1399414B1
(en)
|
2001-04-24 |
2010-01-13 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
US8088820B2
(en)
*
|
2001-04-24 |
2012-01-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
JP2005514410A
(ja)
|
2002-01-08 |
2005-05-19 |
パラテック ファーマシューティカルズ インコーポレイテッド |
4−デジメチルアミノテトラサイクリン化合物
|
EP2316450A1
(en)
|
2002-03-08 |
2011-05-04 |
Paratek Pharmaceuticals, Inc. |
Amino-methyl substituted tetracycline compounds
|
CA2479877C
(en)
|
2002-03-21 |
2012-08-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
JP4416652B2
(ja)
|
2002-07-12 |
2010-02-17 |
パラテック ファーマシューティカルズ インコーポレイテッド |
3、10、および12a置換されたテトラサイクリン化合物
|
EP1556007A4
(en)
|
2002-10-24 |
2008-12-17 |
Paratek Pharm Innc |
SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA
|
JP2006514119A
(ja)
*
|
2003-02-12 |
2006-04-27 |
アール アンド ピー コリア カンパニー リミテッド |
溶解率が向上した難溶性薬剤の溶媒系
|
EP2292590A3
(en)
|
2003-07-09 |
2012-05-02 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
CN101863841A
(zh)
*
|
2003-07-09 |
2010-10-20 |
帕拉特克药品公司 |
取代的四环素化合物
|
US20060287283A1
(en)
*
|
2003-07-09 |
2006-12-21 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
EP2332904A3
(en)
|
2004-01-15 |
2012-04-11 |
Paratek Pharmaceuticals, Inc. |
Derivatives of tetracycline compounds
|
TWI261038B
(en)
*
|
2004-08-11 |
2006-09-01 |
Bo-Cheng Chen |
Bicycle gear-shifting handgrip
|
WO2006047671A2
(en)
*
|
2004-10-25 |
2006-05-04 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
AU2005299569B2
(en)
|
2004-10-25 |
2012-06-07 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
EP1848685A1
(en)
|
2005-02-04 |
2007-10-31 |
Paratek Pharmaceuticals, Inc. |
11a, 12-derivatives of tetracycline compounds
|
DE102005012595A1
(de)
*
|
2005-03-18 |
2006-09-21 |
Lanxess Deutschland Gmbh |
Herstellung von Tri(chlorpropyl)phosphat
|
JP2009502809A
(ja)
*
|
2005-07-21 |
2009-01-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
10−置換テトラサイクリンおよびその使用方法
|
EP1926481A2
(en)
*
|
2005-09-19 |
2008-06-04 |
Albermarle Corporation |
Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
|
US9078811B2
(en)
*
|
2006-01-24 |
2015-07-14 |
Paratek Pharmaceuticals, Inc. |
Methods of increasing oral bioavailability of tetracyclines
|
CN101489987A
(zh)
*
|
2006-04-17 |
2009-07-22 |
特瓦制药工业有限公司 |
四环素衍生物的分离
|
US7871993B2
(en)
*
|
2006-04-24 |
2011-01-18 |
Teva Pharmaceutical Industries Ltd. |
Tigecycline crystalline forms and processes for preparation thereof
|
US8198470B2
(en)
*
|
2006-04-24 |
2012-06-12 |
Teva Pharmaceutical Industries Ltd. |
Crystalline form II of tigecycline and processes for preparation thereof
|
EP2029749A2
(en)
*
|
2006-05-15 |
2009-03-04 |
Paratek Pharmaceuticals, Inc. |
Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
|
US8440646B1
(en)
|
2006-10-11 |
2013-05-14 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of Bacillus anthracis infections
|
CA2673486C
(en)
|
2006-12-21 |
2015-09-08 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of inflammatory skin disorders
|
IL270446B2
(en)
|
2006-12-21 |
2023-10-01 |
Paratek Pharm Innc |
A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
|
US7935687B2
(en)
*
|
2007-04-12 |
2011-05-03 |
Paratek Pharmaceuticals, Inc. |
Methods for treating spinal muscular atrophy using tetracycline compounds
|
JP2010525069A
(ja)
*
|
2007-04-27 |
2010-07-22 |
パラテック ファーマシューティカルズ インコーポレイテッド |
アミノアルキルテトラサイクリン化合物の合成方法および精製方法
|
JP2010532759A
(ja)
|
2007-07-06 |
2010-10-14 |
パラテック ファーマシューティカルズ インコーポレイテッド |
置換テトラサイクリン化合物を合成するための方法
|
BRPI0908951A2
(pt)
|
2008-03-05 |
2017-01-17 |
Paratek Pharm Innc |
compostos de minociclina e método de uso dos mesmos
|
PT2271348T
(pt)
|
2008-03-28 |
2018-04-16 |
Paratek Pharm Innc |
Formulação de comprimido oral de composto de tetraciclina
|
JP2011517697A
(ja)
*
|
2008-04-14 |
2011-06-16 |
パラテック ファーマシューティカルズ インコーポレイテッド |
置換テトラサイクリン化合物
|
TW202216656A
(zh)
|
2008-05-23 |
2022-05-01 |
美商Prtk Spv2公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
WO2010011522A1
(en)
*
|
2008-07-21 |
2010-01-28 |
Albemarle Corporation |
High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
|
US9629809B2
(en)
|
2008-07-21 |
2017-04-25 |
Si Group, Inc. |
High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
|
EA201170425A1
(ru)
*
|
2008-09-19 |
2011-10-31 |
Паратек Фармасьютикалс, Инк. |
Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
|
EP2416799B1
(en)
|
2009-04-10 |
2017-11-01 |
Tufts Medical Center, Inc. |
Par-1 activation by metalloproteinase-1 (mmp-1)
|
CA2835876C
(en)
|
2011-05-12 |
2020-04-14 |
Paratek Pharmaceuticals, Inc. |
Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same
|
EP3534908A4
(en)
|
2016-11-01 |
2020-05-27 |
Paratek Pharmaceuticals, Inc. |
9-AMINOMETHYL-MINOCYCLINE COMPOUNDS AND USE THEREOF IN THE TREATMENT OF AMBULANTLY ACQUIRED BACTERIAL PNEUMONIA (CABP)
|
JP2020527607A
(ja)
|
2017-07-21 |
2020-09-10 |
アルミラール・リミテッド・ライアビリティ・カンパニーAlmirall, Llc |
非炎症性病変の処置
|